Researchers at an Israeli institution report that the active ingredient in Viagra, combined with statins, may prevent cancer metastasis by blocking cholesterol needed for cells to spread, according to Times of Israel. The study used mouse models and data from 5 million health fund members.
In what researchers describe as a world first, Israeli scientists have reported that sildenafil, the active ingredient in Viagra, may help halt cancer metastasis. The study, covered by Times of Israel, suggests that combining erectile dysfunction drugs with statins could block the cholesterol that cancer cells need to spread. The findings were based on mouse models and a large-scale analysis of 5 million members of an Israeli health fund. The researchers caution that the results are preliminary and further clinical trials would be needed before any treatment application.
- DevelopingIsraeli company seeks couples for new male fertility drug trial
- DevelopingIsraeli Doctors Test Ultrasound Therapy for Enlarged Prostate Without Surgery
- DevelopingWarning: antibiotic-resistant bacteria spreading through sex between men spreads twice as fast as regular strains
- DevelopingIsraeli researchers warn drug-resistant 'superbugs' pose growing threat to animal and human vision
Source and signal
A single-sourced dispatch is never rated Confirmed or Strong. Its Signal strengthens only when a second, independent source corroborates it.
- Open-source intake